VolitionRx Ltd
VNRX
34 hedge funds and large institutions have $18.3M invested in VolitionRx Ltd in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 5
47% more call options, than puts
Call options by funds: $192K | Put options by funds: $131K
0.01% more ownership
Funds ownership: 0.56% → 0.57% (+0.01%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less capital invested
Capital invested by funds: $18.7M → $18.3M (-$401K)
6% less funds holding
Funds holding: 36 → 34 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Lagoda Investment Management
New York
|
+$301K |
| 2 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$53.8K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$43.1K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$37.7K |
| 5 |
State Street
Boston,
Massachusetts
|
+$29.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Creative Planning
Overland Park,
Kansas
|
-$51K |
| 2 |
E
Ergoteles
New York
|
-$50K |
| 3 |
Renaissance Technologies
New York
|
-$35K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$34.1K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$17.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $9K | -$2.83K | -50 | -25% |
|
|
CWM
27
CarsonAllaria Wealth Management
Glen Carbon,
Illinois
| $9K | – | – | – |
|
|
FCMT
28
Founders Capital Management (Texas)
Houston,
Texas
| $9K | – | – | – |
|
29
National Bank of Canada
Montreal,
Quebec, Canada
| $3K | – | – | – |
|
30
BNP Paribas Financial Markets
Paris,
France
| $1.04K | – | – | – |
|
31
Wells Fargo
San Francisco,
California
| $1K | – | – | – |
|
32
Citigroup
New York
| $1K | +$964 | +17 | New |
|
|
33
Creative Planning
Overland Park,
Kansas
| – | -$51K | -808 | Closed |
|
|
E
34
Ergoteles
New York
| – | -$50K | -795 | Closed |
|
|
35
Renaissance Technologies
New York
| – | -$35K | -565 | Closed |
|
|
TCWM
36
Total Clarity Wealth Management
St. Charles,
Illinois
| – | -$2K | -36 | Closed |
|
37
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$57 | +1 | New |
|
VNRX Hedge Fund Activity: Q1 2022 in Review
34 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q1 2022, worth a combined $18.3M — down 2.1% from $18.7M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of VNRX and 2 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 10 added.
The largest buyer was Lagoda Investment Management, adding an estimated $301K. The largest seller was Creative Planning, exiting entirely with an estimated $51K sold.
- 34 institutional investors held VolitionRx Ltd (VNRX) as of Q1 2022, down from 36 in Q4 2021.
- Funds reported $18.3M of VolitionRx Ltd stock for Q1 2022, down 2.1% quarter-over-quarter.
- 2 funds opened new VolitionRx Ltd positions in Q1 2022 and 4 closed out, a net change of -2 holders.
- The largest VolitionRx Ltd buyer in Q1 2022 was Lagoda Investment Management, an estimated $301K added.
- The largest VolitionRx Ltd seller in Q1 2022 was Creative Planning, an estimated $51K sold.
Based on aggregated 13F filings for Q1 2022.